Trial
NCT02587871
Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Southern California
Collaborators
National Cancer Institute (NCI)
Condition
Adult Acute Myeloid Leukemia in Remission
Intervention
Cytarabine
Why stopped
PI decided not to pursue study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-09